Adenomas hipofisarios

1 Saeger W, Lüdecke DK, Buchfelder M, Fahlbusch R, Quabbe HJ, Petersenn S. Pathohistological classification of pituitary tumors: 10 years of experience with the German Pituitary Tumor Registry. Eur J Endocrinol 2007; 156:203-16. 10.1530/eje.1.02326 17287410

2 Kreitschmann-Andermahr I, Siegel S, Weber Carneiro R, Maubach JM, Harbeck B, Brabant G. Headache and pituitary disease: a systematic review. Clin Endocrinol (Oxf) 2013;79:760-9. 10.1111/cen.12314 23941570

3 Levy MJ. The association of pituitary tumors and headache. Curr Neurol Neurosci Rep 2011;11:164-70. 10.1007/s11910-010-0166-7 21128024

4 Briet C, Salenave S, Bonneville JF, Laws ER, Chanson P. Pituitary apoplexy. Endocr Rev 2015;36:622-45. 10.1210/er.2015-1042 26414232

5 Arafah BM. Reversible hypopituitarism in patients with large nonfunctioning pituitary adenomas. J Clin Endocrinol Metab 1986; 62:1173-9. 10.1210/jcem-62-6-1173 3009521

6 Reid TJ, Post KD, Bruce JN, Nabi Kanibir M, Reyes-Vidal CM, Freda PU. Features at diagnosis of 324 patients with acromegaly did not change from 1981 to 2006: acromegaly remains under-recognized and under-diagnosed. Clin Endocrinol (Oxf) 2010;72:203-8. 10.1111/j.1365-2265.2009.03626.x 19473180

7 Zarool-Hassan R, Conaglen HM, Conaglen JV, Elston MS. Symptoms and signs of acromegaly: an ongoing need to raise awareness among healthcare practitioners. J Prim

Health Care 2016; 8:157-63. 10.1071/HC15033 27477558

8 Kreitschmann-Andermahr I, Psaras T, Tsiogka M, etal . From first symptoms to final diagnosis of Cushing’s disease: experiences of 176 patients. Eur J Endocrinol 2015; 172:285-9. 10.1530/EJE-14-0766 25501963

9 Nieman LK. Update on subclinical Cushing’s syndrome. Curr Opin Endocrinol Diabetes Obes 2015;22:180-4. 10.1097/MED.0000000000000159 25887388

10 Yoo F, Chan C, Kuan EC, Bergsneider M, Wang MB. Comparison of male and female prolactinoma patients requiring surgical intervention. J Neurol Surg B Skull Base 2018; 79:394-400. 10.1055/s-0037-1615748 30009121

11 Schaller B. Gender-related differences in prolactinomas. A clinicopathological study. Neuro Endocrinol Lett 2005;26:152-9.15855888

12 Drange MR, Fram NR, Herman-Bonert V, Melmed S. Pituitary Tumor Registry: a novel clinical resource. J Clin Endocrinol Metab 2000;85:168-74.10634382

13 Andela CD, Scharloo M, Pereira AM, Kaptein AA, Biermasz NR. Quality of life (QoL) impairments in patients with a pituitary adenoma: a systematic review of QoL studies. Pituitary 2015; 18:752-76. 10.1007/s11102-015-0636-7 25605584